DE60322415D1 - Antikrebs- und antivirale zusammensetzung - Google Patents

Antikrebs- und antivirale zusammensetzung

Info

Publication number
DE60322415D1
DE60322415D1 DE60322415T DE60322415T DE60322415D1 DE 60322415 D1 DE60322415 D1 DE 60322415D1 DE 60322415 T DE60322415 T DE 60322415T DE 60322415 T DE60322415 T DE 60322415T DE 60322415 D1 DE60322415 D1 DE 60322415D1
Authority
DE
Germany
Prior art keywords
anticancer
antique
antiviral composition
composition
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60322415T
Other languages
English (en)
Inventor
Lae-Ok Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020020067293A external-priority patent/KR100925516B1/ko
Priority claimed from KR1020020067291A external-priority patent/KR100932520B1/ko
Priority claimed from KR1020020081951A external-priority patent/KR100428587B1/ko
Priority claimed from KR1020030072732A external-priority patent/KR100428588B1/ko
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60322415D1 publication Critical patent/DE60322415D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DE60322415T 2002-10-31 2003-10-31 Antikrebs- und antivirale zusammensetzung Expired - Fee Related DE60322415D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1020020067293A KR100925516B1 (ko) 2002-10-31 2002-10-31 아연 및 ｌ-아르기닌을 함유한 항암용 조성물
KR1020020067291A KR100932520B1 (ko) 2002-10-31 2002-10-31 항암제 조성물
KR1020020081951A KR100428587B1 (ko) 2002-12-20 2002-12-20 구연산, 아연 및 ｌ-아르기닌을 포함하는 항암제 조성물
KR1020030072732A KR100428588B1 (ko) 2003-10-17 2003-10-17 구연산, 아연 및 ｌ-아르기닌을 포함하는 항 바이러스제조성물
PCT/KR2003/002324 WO2004039379A1 (en) 2002-10-31 2003-10-31 Anticancer or antiviral composition

Publications (1)

Publication Number Publication Date
DE60322415D1 true DE60322415D1 (de) 2008-09-04

Family

ID=32234320

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322415T Expired - Fee Related DE60322415D1 (de) 2002-10-31 2003-10-31 Antikrebs- und antivirale zusammensetzung

Country Status (8)

Country Link
US (2) US20070166401A1 (de)
EP (1) EP1565195B1 (de)
JP (2) JP4603891B2 (de)
CN (1) CN1708310A (de)
AT (1) ATE401901T1 (de)
AU (1) AU2003274800A1 (de)
DE (1) DE60322415D1 (de)
WO (1) WO2004039379A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
KR100656807B1 (ko) * 2005-02-23 2006-12-13 배석년 구연산, 아연 및 아르기닌으로 이루어진 팽창선조 예방 및치료용 조성물
KR20090127925A (ko) * 2007-03-09 2009-12-14 마루이시세이야쿠가부시키가이샤 소독 방법 및 소독용 조성물
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
KR20140026372A (ko) 2011-02-02 2014-03-05 이무노퓨처 아이앤씨. 혈액-뇌 장벽을 투과하는 약물 전달체, 펩티드 및 이의 용도
KR101546802B1 (ko) * 2013-06-12 2015-08-24 박래옥 붕산, 구연산, 아연, 알부민 및 비타민 c를 포함하는 파필로마 바이러스에 대한 항바이러스 피부외용제 조성물
WO2019000163A1 (zh) * 2017-06-26 2019-01-03 余祖江 精氨酸在制备抗肿瘤药物中的用途
KR102664243B1 (ko) * 2018-01-19 2024-05-08 데루타-후라이 화마 가부시키가이샤 암 환자의 치료에 유용한 오줌의 알칼리제
KR102155802B1 (ko) * 2018-09-21 2020-09-14 박래옥 시트르산 및 아르기닌 포함 아연 착화합물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) * 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
GB8410403D0 (en) * 1984-04-24 1984-05-31 Unilever Plc Antiperspirant product
US5599551A (en) * 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
EP0507872B1 (de) * 1989-12-29 2000-04-26 B. Braun Medical Inc. Verwendung von arginin als immunstimulator
KR930002831B1 (ko) * 1990-12-04 1993-04-10 일양약품 주식회사 항종양 면역증강효과가 있는 단백다당체(c 909)
WO1995010534A1 (en) * 1993-10-14 1995-04-20 Seikagaku Corporation Polypeptide and anti-hiv agent prepared therefrom
US6238682B1 (en) * 1993-12-13 2001-05-29 The Procter & Gamble Company Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP2000212088A (ja) * 1999-01-27 2000-08-02 Kobayashi Kako Kk 難溶性抗ウイルス剤の水溶液
GB2359021B (en) * 2000-02-09 2002-04-24 Andromeda Trading Ltd Method and composition for promoting hair growth
KR20030021857A (ko) * 2001-09-08 2003-03-15 주식회사 에코윈 아미노산 음이온-제2구리 착물을 포함하는 항암제 및 이의제조방법
JP4323128B2 (ja) * 2002-01-16 2009-09-02 正 五井野 生理活性組成物
KR100426450B1 (ko) * 2002-03-16 2004-04-13 박래옥 구연산, 알부민 및 아연을 함유한 항암 조성물
US7163919B2 (en) * 2002-03-16 2007-01-16 Seog-Nyeon Bae Anticancer composition

Also Published As

Publication number Publication date
EP1565195B1 (de) 2008-07-23
AU2003274800A1 (en) 2004-05-25
EP1565195A4 (de) 2006-05-10
US20090226538A1 (en) 2009-09-10
JP4603891B2 (ja) 2010-12-22
CN1708310A (zh) 2005-12-14
JP2006506400A (ja) 2006-02-23
JP5232103B2 (ja) 2013-07-10
WO2004039379A1 (en) 2004-05-13
ATE401901T1 (de) 2008-08-15
US20070166401A1 (en) 2007-07-19
EP1565195A1 (de) 2005-08-24
JP2009298800A (ja) 2009-12-24

Similar Documents

Publication Publication Date Title
ES2160046A1 (es) Derivados pentapeptidicos.
WO2019143902A3 (en) Substituted heterocycles as antiviral agents
NO2016021I1 (no) 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2Hpyrido[2,3-D]pyrimidinderivater og relaterte forbindelser for behandling av kreft
WO2002014311A3 (en) Urea compounds and methods of uses
MX2022016405A (es) Análogos de nucleósido de 1¿-ciano y usos de estos.
SG149067A1 (en) IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
SG163517A1 (en) Antiviral compounds and methods
EA202090514A1 (ru) Противовирусное средство против гепатита в
WO2004113365A3 (en) Hepatitis c serine protease tri-peptide inhibitors
MXPA04012965A (es) Inhibidores virales.
MY177111A (en) Substituted amide derivatives and methods of use
TW200630344A (en) Tetracyclic indole derivatives as antiviral agents
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
ECSP055844A (es) Nuevos compuestos triciclicos
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
DE60322415D1 (de) Antikrebs- und antivirale zusammensetzung
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
TR200003065T2 (tr) Nöraminidazların inhibitörleri olarak pirolidinler.
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
EA200501344A1 (ru) Комбинированное применение рибавирина и бета-интерферона при демиелинизирующих заболеваниях
EA202192646A1 (ru) Лиофилизированная композиция, содержащая соединение бензоазепина
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
ATE301997T1 (de) Antivirale therapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee